For private equity sponsors and operators of specialty pharmacies

Therapies, payer contracts, referrals and dispensing volume all rise. Access, service capacity, speed to therapy, margin and cash do not move with them.

The constraint is rarely one workflow or one technology. It is the interaction among referral intake, benefits investigation, prior authorization, financial assistance, dispensing and adherence support.

What grows Therapies · payer contracts · referral sources · patients · dispensing volume · locations
What should follow Faster access decisions · shorter time to therapy · better adherence · reliable delivery · collected cash
Six leverage domains Where scale should create leverage, and why it usually does not.
Therapy portfolio and channel fit
Therapies that fit the patients and payer access.
Opportunity, distribution restrictions and service burden are judged separately.
Referral intake and access
Complete prescriptions and faster access decisions.
Intake, benefits investigation, authorization and assistance stay fragmented.
Onboarding and time to therapy
Patients move reliably from prescription to treatment.
Education, affordability and prescriber follow-up stay manual.
Dispensing and inventory
Better labor and inventory utilization, reliable delivery.
Forecasting, purchasing, cold chain and shipping run separately.
Clinical services and adherence
Support aimed at the patients most likely to persist.
Outreach, refills and monitoring are applied without prioritization.
Revenue, quality and integration
Accurate reimbursement, collected cash, consistent performance.
Reconciliation, underpayments and manufacturer reporting stay fragmented.
The answer is not automatically more technology
The right intervention may be simplification, standardization, a shared capability, better system linkage, conventional automation or selective AI. The objective is the simplest intervention capable of changing the economics.
SCALED · how far the intervention should go An organization may stop at any stage.
S Simplify→ C Codify→ A Aggregate→ L Link→ E Execute automatically→ D Deploy AI selectively
Two decades inside regulated healthcare operations: 30+ regulated products shipped, P&L-owner. Ex-LabCorp, Deployed systems to the VA, NHS, Memorial Sloan-Kettering.
Start with one consequential question
One question involving patient access, time to therapy, dispensing capacity, adherence, margin or cash. A preliminary conversation determines whether it warrants a diagnostic.
Discuss a specialty pharmacy value-creation question →
Arvita Tripati
Value Creation Advisor & CEO, Vahana Labs
arvita@vahanalabs.ai